Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DURATION: Extended Dual Antiplatelet Therapy in Acute Ischemic Stroke of Presumed Atherosclerotic Origin
KCT0004407Phase 4Active, not recruiting
- Sponsor
- Samjin Pharmaceutical Co., Ltd.
- Start
- Jul 2020
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of aspirin, clopidogrel in ischemic stroke, sponsored by Samjin Pharmaceutical Co., Ltd.. Started Jul 2020; status: active, not recruiting.
02
Drugs
aspirinclopidogrel
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on KCT0004407.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0004407.